Gyros Protein Technologies

Press releases and productsPublicationsPanel discussionsWebinarsInterviews

Gyros Protein Technologies introduces Gyrolab Bioaffy 4000 CD to extend sensitivity of immunoassay CD range

Product: Gyrolab® xPand – the automated, high- throughput immunoassay system that maximizes productivity in biotherapeutic discovery, development and production

Application note: Quantitation of Antibody-Drug Conjugates (Gyros)

eBook: the use of automation in the bioanalytical lab

In the Zone: the use of singlicate analysis in LBAs

Gyrolab technology – a must-have in biotherapeutics development and manufacturing

Evaluation of therapeutic antibody performance with multiple nanolitre-scale immunoassays in a single run

Panel discussion: drug development, instrumentation and practical implications of COVID-19

Panel discussion: novel techniques and the new age of biomarkers

Panel discussion: the impact of new technologies

Panel discussion: considerations and challenges of ligand binding assays

Fast and convenient generic LBA for the detection of ADA in monkey plasma using Gyrolab® platform

Singlet analysis using Gyrolab® LBAs, a new normal in abnormal times

Generic PK methods for the quantification of mAbs using Gyrolab® and LC–MS/MS

High-throughput reagent pairing and PK assay development using an automated nanoliter-scale immunoassay platform

Biopharmaceutical drug development: from CMC to clinical PK

People behind the science: an interview with Joy Concepcion (Gyros Protein Technologies)

Interview with Robert Durham (Gyros) on bioanalysis of antibody-drug conjugates

Interview with Rob Durham (Gyros) on automation of assays and the Gyros Immunoassay

International Women’s Day: an interview with Kia Pedersen

International Women’s Day: an interview with Jasmine Gruia-Gray

Bioanalytical Zone profile GPT 2Gyros Protein Technologies provides enabling peptide synthesis and bioanalytical solutions that help scientists increase biomolecule performance and productivity in research, drug discovery, pre-clinical and clinical development, and bioprocess applications. Our low to mid-scale peptide synthesizer platforms are the new PurePep™ Chorus, Tribute®, Prelude® X, Symphony® X, and Sonata® XT. These solutions provide parallel synthesis and along with our chemistries deliver uncompromising purity, flexibility, and quality synthesis for discovery and pre-clinical studies of simple to complex multifunctional peptides. For bioanalysis, our proprietary high performance nanoliter-scale immunoassay platforms, Gyrolab® xPand, Gyrolab® xP workstation and Gyrolab xPlore™, and Gyrolab immunoassay kits, are used by scientists in leading pharmaceutical, biotech, CRO, and CMO companies in the development and manufacturing of various biotherapies including those based on peptides, antibodies, and gene therapies and vaccines. Gyrolab immunoassays provide key workflow advantages of speed, automation, and low reagent usage, and assay quality advantages of wide dynamic range with robust precision and reproducibility in applications including pharmacokinetics/pharmacodynamics, immunogenicity, and analysis of bioprocess-related impurities. Our peptide synthesis and bioanalytical solutions accelerate the discovery, development, and manufacturing of safer biotherapeutics. Gyros Protein Technologies is a division of Mesa Laboratories.

Website: www.gyrosproteintechnologies.com/

Email: [email protected]

Address:
30 Technology Drive, Suite 1F
Warren
New Jersey
07059
United States
Tel: 908 755 0011